Julie Rhie, Ph.D., R.Ph.
Senior Regulatory Affairs Scientist
Pharmacologist
Regulatory Affairs Branch
NCI DCTD Cancer Therapy Evaluation Program
Dr. Julie Rhie joined the Regulatory Affairs Branch in 2001. Her roles include acting as a regulatory liaison for CTEP with the FDA, and as an internal regulatory policy advisor. She oversees a drug development support contract that includes the drafting of INDs, safety reporting and medical writing.
Prior to joining RAB, Dr. Rhie was a Pharmacologist with the Developmental Therapeutics Program, DCTD, NCI and an NIGMS Pharmacology Research Associate Fellow where she was involved in research and regulatory review at CBER, FDA.
She graduated from the Rutgers College of Pharmacy and is a licensed pharmacist. Dr. Rhie received her Doctorate in Pharmaceutics from the University of Michigan specializing in oral absorption pharmacokinetics.